AC
Aurora Cannabis Inc.
ACB · NASDAQ
$3.74 -1.32% (-$0.05)
1M -2.36%
Market Cap $319.7M
P/E Ratio -
Div. Yield -
ROE 21.00%
Bulios Fair Price
$3.1
17.1% downside
Current Price
$3.74
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ACB is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 1.10x
P/B 0.61x
P/E N/A
Growth
68 /100
Growing Rev. growth 12.82%
Book val. growth 1.50%
EPS growth N/A
Profitability
12 /100
Weak Gross margin 32.08%
Net margin 38.15%
Op. margin 29.66%
Quality
6 /100
Poor ROIC 16.50%
ROE 21.00%
ROA 17.83%
Debt
69 /100
Low Debt/Equity 0.04x
Current ratio 5.36x
Int. coverage -14.48x
Stability
31 /100
Unstable Beta 1.34x
Rev. volatility 17.75%
EPS volatility 4,467.05%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ACB
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Miguel Martin
Employees
1,028
Headquarters
Edmonton
Upcoming events
04 NOV
Earnings
Upcoming earnings report